A1M Pharma AB has changed its name to Guard Therapeutics International AB
A1M Pharma develops ROSgard, a biological drug candidate that makes use of one of the most powerful and universal defense systems against oxidative stress in the body.
ROSgard is designed by nature to home in on the kidneys, enabling it to be in place when the kidneys are subjected to oxidative stress. Treatment with ROSgard has the potential to save lives and prevent both acute and chronic kidney injuries, where the reduced kidney function could otherwise lead to serious consequences, such as need for dialysis treatment.
ROSgard prevents oxidative stress-induced damage by utilizing three mechanisms: